Search clinical trials for: clofarabine (IV formulation)

Total 4538 results

Eli Lilly and Company

Completed

A Study of LY2409021 Formulations and the Effect of Food

Healthy Volunteers

Singapore
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without Food

Healthy

Germany
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Leukemia

United States
Sanofi Pasteur, a Sanofi Company

Completed

A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in Canada

Tetanus Immunisation (Healthy Volunteers) | Diphtheria Immunisation (Healthy Volunteers) | Pertussis Immunisation (Healthy Volunteers)

Canada
GlaxoSmithKline

Completed

A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations

Analgesia

United States
H. Lundbeck A/S

Completed

Bioequivalence Study of Idalopirdine Tablets 60 mg

Healthy

United Kingdom
Severance Hospital

Completed

Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male Volunteers

Healthy

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Influenza

United States
Boehringer Ingelheim

Completed

Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers

Healthy
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Influenza, Human

United States
Colorado State University

Completed

Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

Pharmacokinetics | Metabolism | Liver Function

United States
Inventprise Inc.
PATH; Canadian Center for Vaccinology; Vaccine Evaluation Center, Canada

Active, not recruiting

Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Pneumococcal Vaccines

Canada
Shi Yun

Recruiting

Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics (JJGS and POI)

Traditional Chinese Medicine | Metabolomics | Premature Ovarian Insufficiency | Clinical Syndrome | Mechanism

China
Lallemand Health Solutions

Recruiting

Efficacy and Safety of a Probiotic Formulation in Adults With Irritable Bowel Syndrome With Diarrhea (IBS-D)

IBS - Irritable Bowel Syndrome

Turkey
Lallemand Health Solutions

Completed

Probiotics on Sleep Among Adults Study

Sleep Disturbance | Sleep Patterns

Canada
Lallemand Health Solutions
ProbiSearch SL

Withdrawn

The Effect of Probiotics on Symptoms of Infantile Colic (PROCOLIN)

Colic

Spain
The Netherlands Cancer Institute

Completed

Study With Improved Solubility Pazopanib

Pharmacokinetics of Pazopanib

Netherlands
Nestlé

Completed

Efficacy of a Probiotic Formulation on Energy Balance in Overweight Subjects

Healthy

Switzerland
Advagene Biopharma Co. Ltd.
Gadjah Mada University

Recruiting

Evaluating the Safety and Efficacy of AD17002 Intranasal Spray in Treating Participants With Mild to Moderate COVID-19

COVID-19

Indonesia
Severance Hospital

Completed

Safety and Pharmacokinetic Comparison of Co-administration and a Combination Drug of Rosuvastatin and Olmesartan in Healthy Male Volunteers

Healthy

Korea, Republic of
University of Maryland, Baltimore
Chinese University of Hong Kong; National Center for Complementary and Integrative...

Completed

Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) (TCM-IBS)

Irritable Bowel Syndrome

Hong Kong
University of Missouri-Columbia
Nutramax Laboratories, Inc.

Completed

Nutramax Joint Health Formulation Biochemical Response Study

Osteoarthritis, Knee

United States
Biopolis S.L.
Korott, S.L.

Completed

Intervention Study to Evaluate a Probiotic in Mild Atopic Dermatitis Young Patients

Dermatitis, Atopic

Spain
Bayer

Completed

Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)

Dermatitis, Atopic

Germany
Cylene Pharmaceuticals

Unknown

Dose-escalation Study of Oral CX-4945

Breast Cancer | Multiple Myeloma | Advanced Solid Tumors | Inflammatory Breast Cancer | Castleman's Disease

United States
Chong Kun Dang Pharmaceutical

Completed

Pharmacokinetics and Safety Profile of CKD-333

Hypertension | Dyslipidemias

Korea, Republic of
Tomorrowlabs GmbH

Unknown

Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging (REDUCEAGE)

Aging
Repros Therapeutics Inc.

Completed

Comparison of Two Formulations of Proellex for Oral Administration

Healthy

United States
University of Zurich
Ixodes GmbH; Appletree AG

Completed

Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation (IXO-01)

Lyme Disease

Switzerland
Pfizer

Completed

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Obesity | Overweight

United States
Pendulum Therapeutics

Terminated

Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabetes

Type 2 Diabetes Mellitus

Ireland
University of Oxford
The Hospital for Sick Children; KEMRI-Wellcome Trust Collaborative Research... and other collaborators

Completed

Reformulated F75 Milk to Treat Severe Acute Malnutrition (F75)

Malnutrition | Metabolic Disturbance | Diarrhoea

Kenya, Malawi
Pfizer

Active, not recruiting

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons. It Will Be Given Twice Over a Period of Time to Healthy Adults

Clostridoides Difficile Associated Disease

United States
GlaxoSmithKline

Completed

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Infections, Papillomavirus

Belgium, United States
Lyndra Inc.

Terminated

Study Determining Gastric-Retentive and Modified Release Properties of Prototype Capsules in Healthy Subjects

Healthy | Gastric Retention

United Kingdom
University of Utah
Genzyme, a Sanofi Company

Terminated

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Cancer | Chronic Myelomonocytic Leukemia

United States
Bavarian Nordic

Completed

A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects

Smallpox

United States
Repros Therapeutics Inc.

Completed

Proellex® Pharmacokinetic Bridging Study II (PK)

Healthy

United States
Ian McGowan
National Institute of Allergy and Infectious Diseases (NIAID); CONRAD

Completed

A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally

HIV Prevention

United States
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

The Cultural Formulation Interview-Engagement Aid (CFI-EA)

Communication | Adherence, Patient

United States
Mati Therapeutics Inc.

Completed

A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG

Ocular Hypertension | Glaucoma

United States
Cogent Biosciences, Inc.

Recruiting

(Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis

Mastocytosis | Mastocytosis, Systemic | SSM | Mastocytosis, Indolent

United States, Italy, Canada, Australia, Spain, Switzerland, Norway, United Kingdom, Belgium, Poland, Netherlands, Germany, France, Czechia, Greece, Ireland
GlaxoSmithKline

Completed

Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions

Infections, Bacterial

South Africa
Sanofi

Completed

Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects

Influenza | Myxovirus Infection | Orthomyxoviruses

United States
Genzyme, a Sanofi Company

Completed

A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Lymphoblastic Leukemia, Acute, Childhood

United States
GlaxoSmithKline

Completed

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Respiratory Syncytial Virus Infections

United States, Australia, Germany, Czechia
Karolinska Institutet

Not yet recruiting

Evaluation of the Cultural Formulation Interview (CFI)

Mental Health Issue

Sweden
MediWound Ltd

Completed

A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg Ulcers

Diabetic Foot Ulcer | Venous Leg Ulcer

United States
Bayer

Completed

In-home Use Test of the New Modified Diprobase Formulation to Assess the Safety and Tolerability in Infants and Children Under Physician's Control

Atopic Dermatitis

United Kingdom
Hamdard University

Completed

Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen

H.Pylori Infection

3

Subscribe